It has been proposed that strategies aimed at the prevention of amyloid precursor protein (APP) palmitoylation through the development of specific inhibitors could prevent and/or treat Alzheimer's disease (reviewed in [29]). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.